TDM-Guided Dalbavancin Treatment for Complex <i>Staphylococcus aureus</i> Osteoarticular Infections in Children

<b>Background/Objectives</b>: Dalbavancin is approved for pediatric acute bacterial skin and skin structure infections (ABSSSIs), yet real-world practice frequently necessitates off-label use for deep-seated infections requiring prolonged suppression. While adult data support therapeutic drug monito...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Silvia Garazzino, Giulia Mazzetti, Matteo Sandei, Raffaele Vitale, Camilla Martino, Alice Palermiti, Amedeo De Nicolò, Elisa Funiciello, Alessandro Aprato, Alessia Gerace, Alessandro Bondi, Antonio Curtoni, Antonio D’Avolio, Marco Denina
Formato:	Artigo
Idioma:	Inglês
Publicado em:	MDPI AG 2026-02-01
coleção:	Antibiotics
Assuntos:	dalbavancin pharmacokinetics therapeutic drug monitoring children
Acesso em linha:	https://www.mdpi.com/2079-6382/15/2/162
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!